top semaglutide Injectable | Compounded GLP-1 Semaglutide vs. Tirzepatide 💉, Both

Adverse Reactions/Side Effects The following serious adverse reactions are described below or elsewhere in the prescribing information: Risk of Thyroid C-cell Tumors [see Warnings and Precautions (5.1)] Acute Pancreatitis [see Warnings and Precautions (5.2)] Diabetic Retinopathy Complications [see Warnings and Precautions (5.3)] Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin [see Warnings and Precautions (5.5)] Acute Kidney Injury Due to Volume Depletion [see Warnings and Precautions (5.6)] Severe Gastrointestinal Adverse Reactions [see Warnings and Precautions (5.7)] Hypersensitivity Reactions [see Warnings and Precautions (5.8)] Acute Gallbladder Disease [see Warnings and Precautions (5.9)] Pulmonary Aspiration During General Anesthesia or Deep Sedation [see Warnings and Precautions (5.10)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice

Designed for once-monthly dosing and potentially titration-free administration

However, there may be subtle differences in their potency and duration of action, which could account for some of the observed differences in effectiveness between the two drugs

Wegovy tablets offer a needle-free oral GLP-1 option, using the same active ingredient and with comparable weight loss results to the Wegovy injection

However, the potential risks of SARMs include liver toxicity, cardiovascular disease, and prostate cancer